ReCor Medical, Inc.

Medtronic 's cardiovascular business achieved at least three important long-term goals in the last three months, highlighted by the long-awaited US regulatory approval of its Symplicity Spyral radiofr

As expected, ReCor Medical ’s Paradise ultrasound renal denervation system is now the first RDN system to earn US Food and Drug Administration approval. The FDA approved Paradise as an adjunctive opt

Medtronic ’s long struggle to launch its Symplicity Spyral renal denervation (RDN) technology on the US market is not going to get any easier following a mixed review by the US Food and Drug Administr

ReCor Medical , part of Otsuka Holdings Co , appears to have bypassed Medtronic in the race to launch the first renal denervation (RDN) system in the US. RDN is a catheter-based nerve-ablation proc